SEC Form 4 · accession 0001192482-18-000227
Tabula Rasa HealthCare, Inc. · TRHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glen R Bressner
Director
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 5:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 16, 2018 | S | 25,000 | $48.67 | D | 79,387 | I | As trustee of family trust |
| Common StockF2,F3 | May 16, 2018 | S | 2,165 | $48.27 | D | 25,886 | D | |
| Common StockF4 | May 17, 2018 | S | 25,000 | $50.89 | D | 54,387 | I | As trustee of family trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.90 to $49.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (4) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.15 to $48.49, inclusive.
- F3Includes shares received in a pro rata, in-kind distribution to partners by Originate Growth GP, LLC. Such shares had previously been reported as being held indirectly by the Reporting Person through Originate Growth GP, LLC.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.89 to $51.72, inclusive.